PGR and breast carcinoma: Given that ZNF276 expression was not significantly correlated with estrogen receptor (ER) and progesterone receptor (PR) (Table 1), and ZNF276 did not show a significant expression characteristic in any specific subtype at the tissue and cellular levels (Fig. 1F–H), we speculated that ZNF276 expression was not significantly correlated with breast cancer subtypes.